We are delighted to announce that MAC Clinical Research has received approval for the French Research Tax Credit (Crédit d’impôt recherche, CIR) for Research and Development activities. The CIR is a significant tax incentive in France, facilitating partial funding for research, development, and experimentation activities undertaken by companies, either through reimbursement or corporate tax reduction. This approval status is beneficial to our French biotech and pharma company sponsors, as they can benefit from the tax credit advantage when they work with MAC.
